| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 10/10/2001 | EP1140068A1 Doramectin formulations |
| 10/10/2001 | EP1140045A2 Homer a new target of treating psychiatric disorders |
| 10/10/2001 | EP1140042A1 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites |
| 10/10/2001 | EP1083172A4 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 10/10/2001 | CN1317006A Antiparasitic artemisinin derivatives (endoperoxides) |
| 10/10/2001 | CN1316991A Azetidine derivatives, preparation and medicines containing them |
| 10/10/2001 | CN1072654C Benzamide derivative, composition containing said derivative and use thereof |
| 10/10/2001 | CN1072492C Use of basket fern effective parts in preparing antimalarial drug |
| 10/10/2001 | CN1072485C Use of fumagillo and derivatives thereof for preparing medicaments against intestinal infections |
| 10/10/2001 | CA2343344A1 Erythromycin a derivatives |
| 10/09/2001 | US6300341 2-substituted heterocyclic sulfonamides |
| 10/09/2001 | US6300316 C-4 substituted macrolide antibiotics |
| 10/04/2001 | WO2001072960A2 Il-8 receptor antagonists |
| 10/04/2001 | WO2001072831A2 Immunoregulator |
| 10/04/2001 | WO2001072777A2 Human transcription factors |
| 10/04/2001 | WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders |
| 10/04/2001 | WO2001072728A2 Novel piperazine derivatives |
| 10/04/2001 | WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 10/04/2001 | WO2001072277A2 Immunotherapeutic methods and compositions |
| 10/04/2001 | WO2001019828A3 Kinase inhibitors as therapeutic agents |
| 10/04/2001 | US20010027201 Non-systemic control of parasites |
| 10/04/2001 | US20010026794 Two heterologous DNA encoding gene products; prolonged half-life |
| 10/04/2001 | EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 10/04/2001 | EP1137639A1 Control of arthropods in animals |
| 10/04/2001 | EP1137437A1 Reagent and method for detecting a cryptosporidium parvum sporozoite antigen |
| 10/04/2001 | EP1137411A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 10/04/2001 | EP0815081B1 Piperidinyl-2-alkyl substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| 10/04/2001 | EP0650482B1 Pesticidal pyrimidine compounds |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2402735A1 Human transcription factors |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/04/2001 | CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 10/03/2001 | CN1315954A Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas |
| 10/03/2001 | CA2343452A1 Method of treating a parasitic infection |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297253 Inactivating a nuclear localization signal of a protein comprising contacting the protein with an aryl carbonyl compound that forms stable reversible covalent interactions with neighboring basic amino acid residues |
| 10/02/2001 | US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070232A1 Protease inhibitors |
| 09/27/2001 | WO2001019829A3 Pyrazolopyrimidines as therapeutic agents |
| 09/27/2001 | US20010024658 A delayed release pharmaceutical dosage form for oral administration of heparin comprising a low molecular weight heparin, a bile salt or acid, and a surfactant selected from hydrophilc and lipophilic, and a means for sustained release |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404206A1 Protease inhibitors |
| 09/27/2001 | CA2404112A1 Sustained release delivery systems for solutes |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2401728A1 Difluorobutyric acid metalloprotease inhibitors |
| 09/27/2001 | CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/26/2001 | EP1136081A1 Sustained-release compositions for the parenteral administration of macrolides |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135400A1 Hygromycin a derivatives as antibacterial agents |
| 09/26/2001 | EP1135138A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 09/26/2001 | EP0804581B1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
| 09/26/2001 | CN1314812A Formulations for controlling human lice |
| 09/25/2001 | US6294536 Triazine derivatives, their production and use |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/20/2001 | WO2001068802A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/20/2001 | WO2001068570A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068569A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068568A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068144A2 Biodegradable immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068091A1 Inhibition of fungi |
| 09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | WO2001013942A3 Trehalose producing prokaryotic cells as vaccines |
| 09/20/2001 | US20010023257 Hypotensive agents; anticholesterol agents |
| 09/20/2001 | US20010022970 Halogenated xanthan compound |
| 09/20/2001 | CA2403679A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403062A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2402891A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2402549A1 Substituted beta-carbolines |
| 09/19/2001 | EP1133500A1 Organophosphorous compounds and the use thereof |
| 09/19/2001 | EP1133319A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 09/19/2001 | EP1133302A2 Use of phosphonoformic acid derivatives for treating infections |
| 09/19/2001 | EP0692964B1 Ionene polymers as anthelmintics in animals |
| 09/19/2001 | EP0594667B1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 09/19/2001 | CN1313088A Liquid propanethiophenyl imidzole for expelling parasites from body of livestock and its preparing process |
| 09/18/2001 | US6291488 Administering 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone and 1-(4-chlorophenyl)-5-isopropylbiguanide hydrochloride in a ratio of 1:1 to 3:1. |
| 09/18/2001 | US6291480 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 09/18/2001 | US6291472 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo[3′,4′:4, 5]furo[3,2-b] pyri-dine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation |
| 09/18/2001 | US6291217 Glutathionylspermidine synthetase and processes for recovery and use thereof |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/13/2001 | WO2001066785A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066529A1 Nematicidal trifluorobutenes |
| 09/13/2001 | WO2001066525A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | WO2001066126A1 Sialoadhesin factor-2 antibodies |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001066098A2 Therapeutic uses of ppar mediators |
| 09/13/2001 | WO2001005480A3 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 09/13/2001 | US20010021716 Using agonist of nicotinergic acetylcholine receptors |